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Summary This paper describes the effect of including 'death certificate only' (DCO) registrations on 5 year
relative survival rates for colorectal cancer in four district health authorities (DHAs) in south-east England. A
retrospective case note study was set up to examine all cases of colorectal cancer listed in the Thames Cancer
Registry (TCR) as having been diagnosed in 1983 and 1988 and resident in one of four districts, A, B, C and
D. A total of 673 sets of case notes were requested from all hospitals within the four districts, including 150
sets on DCO cases. Of 465 (69%) sets of case notes retrieved, 378 (72.3%) were non-DCO cases. Of these, 14
were excluded from survival analysis because of missing dates of diagnosis or death in the notes. Eighty-seven
(58.0%) sets of case notes were retrieved on DCO registrations, of which seven were excluded because no date
of diagnosis was available in the notes. Retrieval rates on case note registrations varied by DHA of residence:
73.3% in DHA A, 96.6% in DHA B, 34.5% in DHA C and 79.2% in DHA D. The corresponding figures for
DCO registrations were 63.5%, 69.0%, 7.4% and 76.2%. Cumulative relative 5 year survival rates by DHA of
residence were calculated first for cases registered from case notes and then for all cases including those
registered solely from a death certificate. The total number of cases used in the survival analysis was 444 (18%
DCOs). In all four DHAs, 5 year survival decreased with the inclusion of DCO registrations: by 9.1% in
district A (from 52.8 to 43.7), by 4.5% in district B (from 59.6 to 55.1), by 4.8% in district C (from 80.0 to
75.2) and by 7.6% in district D (from 31.4 to 23.8). The overall reduction in survival was 8.6%. The exclusion
of death certificate only registrations from survival data is an important source of bias. Using TCR data, we
compared DCO proportions for colorectal cancer with other sites. DCO proportions were shown to vary by
tumour site and survival time. The DCO registration is an important quality measure of ascertainment and
follow-up. OPCS should publish DCO proportions by registry area and cancer site. Registries should
implement DCO monitoring as part of quality improvement programmes.
The Office of Population Censuses and Surveys (OPCS) pub-
lishes national 5 year cancer survival statistics, derived from
returns made by the 12 cancer registries in England and
Wales (OPCS and Cancer Research Campaign, 1981). The
accuracy of these statistics depends on the completeness of
case ascertainment by the registries and on the completeness
and accuracy of the data sources from which registrations are
made. Although registration is voluntary, ascertainment is
estimated to be around 90% for the country as a whole
(Villard-Mackintosh et al., 1988). The main data sources for
cancer registration are clinical case notes and copies of death
certificates forwarded by OPCS to each registry on every
person dying on its territory for whom cancer is mentioned.
Death certificate notification enables registries to identify
cases not registered in life. At Thames Cancer Registry
(TCR), the focus of this report, around 50% of the cases
identified by death certificate will have already been
registered. For the remainder, the death certificate is the first
evidence obtained by a registry of the case and is used to
initiate a new registration, termed a death certificate-initiated
registration (DCI) (Jensen et al., 1991; Thames Cancer Regis-
try, 1992a-d). If, on the basis of death certificate inform-
ation, a place of treatment can be traced, the registry
attempts to obtain confirmation of the diagnosis from the
hospitals nearest to the place of death, the certifying
physician or coroner. This process is called retrospective
follow-up. If no further information is obtained on a DCI
registration during the follow-up period (6 months), the case
is deemed a death certificate only registration (DCO) (Jensen
et al., 1991).
DCO registrations are important for two reasons. First,
high proportions of DCOs cast doubt on the accuracy of
cancer registry incidence data: Percy et al. (1981) reported
only 65% accuracy in the coding of cause of death in death
certificates on cancer patients. Second, because it is not
usually possible to confirm the date of diagnosis for a DCO
registration, they are excluded from cancer registry and
OPCS survival analysis.
Historically, DCO registrations were based only on those
cases that remained unregistered after intensive and extended
searches for information on tumour site and date of diag-
nosis. Since 1983, a rapid increase has taken place in Thames
DCO rates. The registry has explained this rise by reference
to the decision taken in 1983 (for financial reasons) not to
follow up patients dying at home (Thames Cancer Registry,
1992a). Since 1992, it has been attempting to retrieve data on
DCO cases (including those patients dying at home) through
Family Health Services Authorities (FHSAs).
A second reason for the high rate was the amalgamation
of the North Thames Regions, which only became part of the
territory covered by the TCR in 1985: the greatest concentra-
tion of DCOs was found in North-East Thames Region.
In 1990 in an ecological analysis of all cases of colorectal
cancer registered by the Thames Cancer Registry and diag-
nosed between 1982 and 1988, we showed significant varia-
tions in 5 year survival rates and DCO proportions across
the 28 districts in the two south Thames regions (Pollock et
al., 1994). To investigate the underlying reasons for these
differences, we undertook a retrospective case note study in
four of those districts (the two with the best survival and the
two with the worst survival) (Vickers & Pollock, 1993; Pol-
lock & Vickers, 1994a). In order to ascertain the extent to
which the observed survival differences were artefactual (the
result of differences in retrospective follow-up of DCI regist-
rations), we also requested notes on all DCO registrations.
This paper examines the effect on 5 year survival rates of
including cases registered by DCO for which it was possible
to retrieve case notes and discusses the implications of our
findings for national cancer survival statistics and the use of
cancer registries for epidemiological and health services
research.
Methods
Between 1991 and 1993 we requested case notes on all cases
which were diagnosed in 1983 and 1988 and resident in the Correspondence: A.M. Pollock.
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four districts identified and which were diagnosed or treated
in their district of residence. Most patients are diagnosed and
treated in their district of residence (83%, 88%, 73% and
79% in districts A, B, C and D respectively) (Vickers &
Pollock, 1993). Case notes were requested from five medical
record sites covering six NHS hospitals and outlying out-
patient departments in the four districts.
Relative survival is the ratio of the survival observed in a
group of cancer patients to the survival expected if they were
only subject to the general (all-cause) mortality in a standard
population. Using the Hakulinen computer program
(Hakulinen et al., 1988), we calculated cumulative 5 year
relative survival rates by DHA of residence for (a) non-DCO
cases, to obtain conventional survival rates, and (b) all cases
including DCO cases for which we were able to ascertain a
date of diagnosis from case notes. (Note that both analyses
include only patients treated in their district of residence.)
Results
Of the 673 cases identified from the TCR, 150 were DCO
registrations (i.e. DCOs accounted for 22.3% of the total
sample). A total of 465 (69.0%) sets of case notes were
retrieved. Three hundred and seventy-eight sets of case notes
were retrieved for non-DCO cases, 14 of which had to be
excluded from survival analysis because of missing dates of
diagnosis or death. Eighty-seven sets of case notes were
retrieved for DCO registrations, seven of which had to be
excluded because no date ofdiagnosis was listed in the notes.
None of the DCOs for which case notes were found were
diagnosed on the date they died.
Table I shows that retrieval rates on case note registrations
varied by DHA of residence: 73.3% in DHA A, 96.6% in
DHA B, 34.5% in DHA C and 79.2% in DHA D and 72.3%
overall. The corresponding figures for DCO registrations
were 63.5%, 69.0%, 7.4%, 76.2% and 58.0%.
The impact of DCOs on survival in all four DHAs com-
bined is shown in Figure 1. Five year survival rates for
colorectal cancer by the conventional method (excluding
DCO cases) was 49.3%; when retrieved DCO cases were
included survival rates fell to 40.9%. The 5 year survival rate
Table I Retrieval rates by district of
registration
residence and source of
Case note registrations DCO registrations
DHA n % n %
A 121/165 73.3 33/52 63.5
B 141/146 96.6 20/29 69.0
C 40/116 34.5 2/27 7.4
D 76/96 79.2 32/42 76.2
Total 378/523 72.3 87/150 58.0
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Figure I The impact of DCO cases on colorectal cancer 5 year
relative survival rate (RSR) (n = 444). 0, Excluding DCOs; 0,
including DCOs; A, DCOs.
for the DCO group only was 7.3%. (DCOs constituted
18.0% of the 444 cases included in the survival analysis.)
The impact of DCOs on each of the four districts survival
rates is shown in Table II. In all four DHAs, 5 year survival
decreased with the inclusion of DCO registrations, district A
by 9.1% (from 52.8 to 43.7), by 4.5% in district B (from 59.6
to 55.1), by 4.8% in district C (from 80.0 to 75.2) and 7.6%
in district D (from 31.4 to 23.8). The greatest survival
differences occurred during the first year from diagnosis.
District D, which had the highest proportion of DCOs and
the best DCO retrieval rate, had the largest decrease in 1
year relative survival (9.6%).
Discussion
Our results suggest that conventionally derived cancer sur-
vival rates can be artefactually high, because of exclusion of
cases registered only from a death certificate: these cases
typically have very short survival times. Our original sample
included 22.3% DCOs. Notes were retrieved on 58.0% of
these, and DCOs accounted for 18% of the records analysed
for survival. Overall 5 year relative survival fell from 49.3%
to 40.9% when DCOs were included. Most of the survival
difference occurred during the first year from diagnosis and
was carried forward in subsequent years. This might be
expected given that the probability of registration from case
notes should increase with longer survival time (Pollock &
Vickers, 1994b).
The retrieval rate of 72.3% for non-DCO cases is lower
than the rate we had hoped to achieve: this was partly
because 108 (29.6%) cases had been diagnosed in 1983, i.e.
10 years before case notes were requested, and partly because
of differences in the operation of medical records depart-
ments across the four districts (Vickers & Pollock, 1993).
Because of the possibility of selection bias in the unretrieved
cases, we did not carry out significance tests on the two sets
of relative survival rates (including and excluding cases
registered by DCO).
Five year survival rates fell by between 4.5% and 9.1%
across the four districts when DCO cases were included. We
could not establish how much of this variation was due to
differences in case note retrieval on DCOs across districts,
and how much to differences in the proportion of DCOs
across districts. Nonetheless, this result has important imp-
lications for health services research and evaluation,
Table II Comparison of cumulative relative 5 year survival rates
(%) for all cases in the conventional analysis (i.e. excluding DCOs)
and all cases including DCOs by DHA of residence
Including traced DCO
Conventional analysis cases
DHA Years % n % n
A 1 68.2 119 62.1 150
2 52.5 77 48.7 88
3 48.7 56 42.2 65
4 49.6 49 42.4 53
5 52.8 47 43.7 50
B 1 82.4 134 78.1 153
2 68.2 105 63.3 113
3 63.2 82 59.3 86
4 60.3 72 56.4 76
5 59.6 65 55.1 68
C 1 90.7 36 88.6 38
2 80.2 31 78.7 32
3 71.5 26 67.5 27
4 75.5 22 71.1 22
5 80.0 22 75.2 22
D 1 54.1 76 44.5 103
2 42.8 39 33.2 43
3 32.6 29 25.9 30
4 29.5 21 23.9 22
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especially if districts with poor follow-up of DCIs appear to
have better treatment and survival rates than areas with good
retrospective follow-up (Silman & Evans, 1981). Our study
on colorectal cancer suggests that the exclusion of Thames
DCOs appears to improve relative survival but that the
improvement varies across districts.
High proportions of DCO registrations arising from failure
of retrospective follow-up may affect survival from cancers in
other sites. As a separate part of our study, we analysed
Thames Cancer Registry data for all cases registered between
1987 and 1989. We derived 2 year survival rates for the ten
most common tumour sites (n = 113,624) and correlated
these with their corresponding DCO proportions. 1991 was
the most recent year for which complete data on deaths was
available - for this reason only 2 year survival rates were
calculated.
There were marked variations in the proportions of DCOs
by site (data not shown) and a strong negative correlation
between DCO proportions and survival rates (P<0.001). As
we might expect, DCO registrations are more common in
poor survival cancers (since there would be less time to
register these in life), but other sites have higher proportions
than would be expected. In breast cancer, for example, which
has moderate to good survival, DCOs account for 16.7% of
registrations. Since it is unlikely that 16.7% of all breast
cancers are diagnosed only at death or post mortem, DCOs
are likely to have had an impact on survival.
Although OPCS holds no national data on DCO propor-
tions, enquiries reveal that the percentage of DCOs held by
registries varies from 1% to 25% of all registrations (per-
sonal communications, England and Wales cancer registries).
Between 1987 and 1989 23.8% of all registrations (excluding
non-melanoma skin cancers) in the Thames Cancer Registry
were DCOs. Since the TCR contributes up to a third of all
cases to England and Wales national data at OPCS, survival
analysis will lose 8% of all registered cases for the years
1987-89 from the four Thames regions alone. This figure will
be even higher if all the other registries' DCOs are included.
Failure of retrospective follow-up will affect national Cancer
Registry data and in particular the interpretation of epide-
miological trends in incidence and survival.
Conclusion
Incomplete case ascertainment has for a long time been
recognised as an important bias in survival analysis. This
study highlights another important source of bias that can
arise even when case ascertainment is complete: DCO regist-
rations arising through failure of retrospective follow-up. The
exclusion of DCO cases from conventionally calculated sur-
vival will generally lead to artefactually high rates. The
differential effect on district-based survival of excluding
DCOs has important implications for epidemiologically
based needs assessment and the evaluation of health care at
local and national level. Cancer registries should explore the
use of DCO rates as part of their quality control programmes
for case ascertainment and registration. They also need to
assess the impact of death certificate only registrations on
national survival rates for all cancers.
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